scholarly article | Q13442814 |
P2093 | author name string | Yukio Ozaki | |
Shin-ichiro Morimoto | |||
Hisashi Kimura | |||
Hitoshi Hishida | |||
Kazumasa Mori | |||
Kenji Miyagishima | |||
Shigeru Kato | |||
Shinya Hiramitsu | |||
Yasuchika Kato | |||
Ryuji Yoda | |||
P2860 | cites work | Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study | Q28167204 |
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization | Q28283679 | ||
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi | Q34272627 | ||
Heart failure with preserved systolic function. A different natural history? | Q34426719 | ||
The Natural History of Congestive Heart Failure: The Framingham Study | Q34701680 | ||
Anemia in chronic kidney disease and congestive heart failure | Q35069933 | ||
The cardio-renal anaemia syndrome: does it exist? | Q35579855 | ||
Anemia as a risk factor and therapeutic target in heart failure | Q35874578 | ||
The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? | Q35981407 | ||
Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis | Q36336393 | ||
Predictors of mortality and morbidity in patients with chronic heart failure | Q39361079 | ||
Anaemia and heart failure | Q43013351 | ||
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study | Q43636269 | ||
B-type natriuretic peptide predicts sudden death in patients with chronic heart failure | Q43703424 | ||
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure | Q44011684 | ||
Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. | Q44039031 | ||
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations | Q44363438 | ||
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure | Q44565536 | ||
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. | Q46019554 | ||
Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure | Q46792235 | ||
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. | Q46825699 | ||
Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan | Q46883345 | ||
The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events | Q49047965 | ||
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. | Q50690091 | ||
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. | Q51919076 | ||
High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure | Q73193169 | ||
Clinical characteristics and prognosis of hospitalized patients with congestive heart failure--a study in Fukuoka, Japan | Q73477813 | ||
Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function | Q74427916 | ||
Association of creatinine clearance and in-hospital mortality in patients with acute coronary syndromes: the GREECS study | Q79449448 | ||
Clinical value of B-type natriuretic peptide for the assessment of left ventricular filling pressures in patients with systolic heart failure and inconclusive tissue Doppler indexes | Q81288809 | ||
Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study | Q81847255 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chronic heart failure | Q11829287 |
heart failure | Q181754 | ||
P304 | page(s) | 306-312 | |
P577 | publication date | 2010-07-31 | |
P1433 | published in | Heart and Vessels | Q15766690 |
P1476 | title | Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure | |
P478 | volume | 25 |
Q53591921 | A prognostic index for risk stratification for acute heart failure and death in subjects with ischemic cardiomyopathy and cardiac defibrillator. |
Q39494178 | Acidic urine is associated with poor prognosis in patients with chronic heart failure |
Q84711425 | Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention |
Q87353510 | Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study |
Q43735034 | Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases |
Q43771064 | Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients |
Q43673479 | Prognostic value of hemoglobin decline over the GRACE score in patients hospitalized for an acute coronary syndrome. |
Q84853457 | Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis |
Q46006185 | Time to revisit role of transcatheter balloon aortic valvuloplasty: a bridge-therapy to subsequent treatment case report. |
Search more.